ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Lastly
|
232 |
50K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
232
|
50K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Lastly
|
232 |
50K |
9 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
50K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Lastly
|
100 |
25K |
15 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
100
|
25K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
11 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
9 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
21 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
6 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
13 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Lastly
|
55 |
14K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
55
|
14K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
27 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Lastly
|
66 |
17K |
11 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
17K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Lastly
|
66 |
17K |
16 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
17K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Lastly
|
62 |
16K |
29 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
62
|
16K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Lastly
|
58 |
16K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Lastly
|
58 |
16K |
16 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Lastly
|
31 |
10K |
19 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
31
|
10K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Lastly
|
31 |
10K |
18 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
10K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Lastly
|
282 |
73K |
5 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
282
|
73K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Lastly
|
33 |
8.3K |
17 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.3K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Lastly
|
282 |
73K |
8 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
282
|
73K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
126
|
31K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
11 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
126
|
31K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
16 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
126
|
31K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
12 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
126
|
31K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
16 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
126
|
31K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
9 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
126
|
31K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Lastly
|
126 |
31K |
7 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
126
|
31K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Lastly
|
311 |
77K |
9 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
311
|
77K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Lastly
|
311 |
77K |
8 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
311
|
77K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Lastly
|
311 |
77K |
10 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
311
|
77K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Lastly
|
311 |
77K |
7 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
311
|
77K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Lastly
|
197 |
51K |
20 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
197
|
51K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
16 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
9 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
15 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
16 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Lastly
|
1.1K |
295K |
6 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.1K
|
295K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Any help appreciated
|
|
Lastly
|
5 |
1.4K |
11 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
5
|
1.4K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Lastly
|
282 |
73K |
15 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
282
|
73K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Lastly
|
282 |
73K |
21 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
282
|
73K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Lastly
|
63 |
16K |
22 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
63
|
16K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Lastly
|
63 |
16K |
19 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
16K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Lastly
|
39 |
9.2K |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.2K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Lastly
|
39 |
9.2K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.2K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Lastly
|
39 |
9.2K |
8 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
9.2K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Lastly
|
77 |
19K |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
77
|
19K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Lastly
|
77 |
19K |
12 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
77
|
19K
|
12
|
|